Evotec Signs Two Significant Contracts with Roche
Evotec AG announced that it signed two significant service contracts with Roche. These contracts build on the companies' long-standing relationship and Evotec's positive contribution to Roche's discovery projects. They extend the global medicinal chemistry agreement signed in May 2004 for a further 12 months and its medicinal chemistry collaboration in oncology, signed in October 2003, for an additional 2 years.
In the global medicinal chemistry agreement a dedicated team of chemists from Evotec supports all of Roche's European and US research sites in the design and synthesis of high quality compounds for lead finding and optimisation programmes. In the medicinal chemistry oncology collaboration, both companies aim to identify and develop a clinical lead candidate for a priority target within Roche's oncology research.
Other news from the department business & finance
